2015
DOI: 10.1007/s00405-015-3699-1
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic impact of second primary tumors in head and neck cancer

Abstract: The incidence of Second Primary Tumors in the upper aerodigestive tract varies from 5 to 30 %. Most of them are located either in the same anatomical region or in the lungs, and are related to a poor overall survival. Our objective is to assess the incidence of Second Primary Tumors, factors related to its outcome, frequent associations, and impact on overall survival. 27 patients with Second Primary Tumors were reviewed out of 307 with head and neck cancer, between 2002 and 2011. Patients had a minimum follow… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

3
26
0
7

Year Published

2017
2017
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 19 publications
(36 citation statements)
references
References 31 publications
3
26
0
7
Order By: Relevance
“…The theory postulates that multiple cancers may arise independently in the upper aerodigestive tract (UADT) because of prolonged exposure to carcinogens, such as tobacco smoke and alcohol. Second primary malignancies are present in up to 36% of patients with UADT cancer within 20 years of their original diagnosis . Synchronous tumors occur simultaneously with the index cancer and are present in approximately 4% of cases .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The theory postulates that multiple cancers may arise independently in the upper aerodigestive tract (UADT) because of prolonged exposure to carcinogens, such as tobacco smoke and alcohol. Second primary malignancies are present in up to 36% of patients with UADT cancer within 20 years of their original diagnosis . Synchronous tumors occur simultaneously with the index cancer and are present in approximately 4% of cases .…”
Section: Introductionmentioning
confidence: 99%
“…Second primary malignancies are present in up to 36% of patients with UADT cancer within 20 years of their original diagnosis. 2,3 Synchronous tumors occur simultaneously with the index cancer and are present in approximately 4% of cases. 4 The oropharynx is one of the most common sites of synchronous UADT cancers, with the tonsils being the most common site affected.…”
Section: Introductionmentioning
confidence: 99%
“…Pojava novih tumora može biti sinkrona, kada se tumor dijagnosticira unutar 6 mjeseci od dijagnoze inicijalnog tumora, metakrona kada nastaje nakon više od 6 mjeseci od dijagnosticiranja prvog tumora ili simultana kada nastaju paralelno s inicijalnim tumorom. Smatra se da je rizik nastanka sinkronih i metakronih tumora veći kod pacijenata u ranim stadijima tumorske bolesti zbog njihovog boljeg preživljenja u odnosu na pacijente s uznapredovalim tumorima [1][2][3][4][5][6] . Također se smatra da je veći rizik od javljanja drugog primarnog tumora kod ljudi mlađih od šezdeset godina te da raste 3 % na godinu kod pacijenata koji prežive neki od karcinoma glave i vrata [3][4][5][6] .…”
Section: Uvodunclassified
“…Genetska preosjetljivost, imunodeficijencija kao i mogući učinak liječenja primarnog tumora prvenstveno radiokemoterapijom također može imati utjecaj na promjenu sluzničkog epitela kao preduvjet nastanka polja kancerizacije [8][9][10][11][12][13] . Organski sustavi u kojima se može naći ovaj fenomen osim aerodigestivnog trakta su i genitalni, probavni kao i koža [1][2][3][4][5] . S obzirom na lokalizaciju karcinoma na larinksu smatra se da je kod supraglotičnih karcinoma češći drugi primarni tumor nego kod glotičnog karcinoma.…”
Section: Uvodunclassified
“…Their analysis found that patients diagnosed with head and neck cancer had a 36% cumulative risk of developing an additional malignancy within 20 years . Subsequent studies have confirmed the increased risk of SPM in these patients, and have demonstrated that a second malignancy significantly diminishes long‐term prognosis . These findings highlight the importance of assessing for additional malignancy and identifying risk factors in order to maximize patient outcomes.…”
mentioning
confidence: 97%